Unknown

Dataset Information

0

Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients.


ABSTRACT: Anti-zinc transporter (ZnT)8 autoantibodies are commonly detected in type 1 diabetic patients. We hypothesised that ZnT8 is also recognised by CD8(+) T cells and aimed to identify HLA-A2 (A*02:01)-restricted epitope targets.Candidate epitopes were selected by ZnT8 plasmid DNA immunisation of HLA-A2/DQ8 transgenic mice and tested for T cell recognition in peripheral blood mononuclear cells of type 1 diabetic, type 2 diabetic and healthy participants by IFN-? enzyme-linked immunospot.White HLA-A2(+) adults (83%) and children (60%) with type 1 diabetes displayed ZnT8-reactive CD8(+) T cells that recognised a single ZnT8(186-194) (VAANIVLTV) epitope. This ZnT8(186-194)-reactive fraction accounted for 50% to 53% of total ZnT8-specific CD8(+) T cells. Another sequence, ZnT8(153-161) (VVTGVLVYL), was recognised in 20% and 25% of type 1 diabetic adults and children, respectively. Both epitopes were type 1 diabetes-specific, being marginally recognised by type 2 diabetic and healthy participants (7-12% for ZnT8(186-194), 0% for ZnT8(153-161)).ZnT8-reactive CD8(+) T cells are predominantly directed against the ZnT8(186-194) epitope and are detected in a majority of type 1 diabetic patients. The exceptional immunodominance of ZnT8(186-194) may point to common environmental triggers precipitating beta cell autoimmunity.

SUBMITTER: Scotto M 

PROVIDER: S-EPMC3740540 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients.

Scotto M M   Afonso G G   Larger E E   Raverdy C C   Lemonnier F A FA   Carel J C JC   Dubois-Laforgue D D   Baz B B   Levy D D   Gautier J F JF   Launay O O   Bruno G G   Boitard C C   Sechi L A LA   Hutton J C JC   Davidson H W HW   Mallone R R  

Diabetologia 20120420 7


<h4>Aims/hypothesis</h4>Anti-zinc transporter (ZnT)8 autoantibodies are commonly detected in type 1 diabetic patients. We hypothesised that ZnT8 is also recognised by CD8(+) T cells and aimed to identify HLA-A2 (A*02:01)-restricted epitope targets.<h4>Methods</h4>Candidate epitopes were selected by ZnT8 plasmid DNA immunisation of HLA-A2/DQ8 transgenic mice and tested for T cell recognition in peripheral blood mononuclear cells of type 1 diabetic, type 2 diabetic and healthy participants by IFN-  ...[more]

Similar Datasets

| S-EPMC5701626 | biostudies-literature
| S-EPMC3107317 | biostudies-literature
| S-EPMC26240 | biostudies-literature
| S-EPMC4790940 | biostudies-literature
| S-EPMC2323292 | biostudies-literature
| S-EPMC8352664 | biostudies-literature
| S-EPMC3684606 | biostudies-literature
| S-EPMC3044399 | biostudies-literature
| S-EPMC3510254 | biostudies-literature
| S-EPMC8804355 | biostudies-literature